Spots Global Cancer Trial Database for stage i breast cancer
Every month we try and update this database with for stage i breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | NCT00003016 | Breast Cancer | tamoxifen citra... adjuvant therap... | - | National Cancer Institute (NCI) | |
| IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer | NCT00041223 | Breast Cancer Radiation Fibro... | IH636 grape see... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer | NCT00005587 | Breast Cancer | radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy | NCT01487954 | Radiation Toxic... Recurrent Breas... Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | alkaline water distilled water external beam r... | 18 Years - | Case Comprehensive Cancer Center | |
| To Detect Cryoimmunologic Response Induced by Early Breast Cancer Ultrasound-guided Cryoablation (ICE-study) | NCT05727813 | Cancer, Treatme... Tumor of Breast Systemic Inflam... Stage I Breast ... | cryoablation | 18 Years - | University of Roma La Sapienza | |
| Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer | NCT01100489 | Ductal Breast C... Estrogen Recept... Estrogen Recept... HER2-negative B... HER2-positive B... Invasive Ductal... Invasive Lobula... Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Progesterone Re... Stage I Breast ... Stage II Breast... Tubular Ductal ... | external beam r... questionnaire a... therapeutic con... | 18 Years - | Case Comprehensive Cancer Center | |
| Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer | NCT00002720 | Breast Cancer | tamoxifen citra... conventional su... | 65 Years - 80 Years | National Cancer Institute (NCI) | |
| Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors | NCT01113554 | Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | questionnaire a... exercise interv... quality-of-life... survey administ... management of t... psychosocial as... | 18 Years - | Wake Forest University Health Sciences | |
| Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer | NCT00337233 | Breast Cancer Fatigue Ovarian Cancer Psychosocial Ef... | yoga therapy | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Compliance to a Hormone Therapy Regimen in Breast Cancer | NCT00666822 | Breast Cancer | compliance moni... medical chart r... questionnaire a... | 18 Years - | Case Comprehensive Cancer Center | |
| Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole | NCT00316836 | Breast Cancer | mammography | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer | NCT00003654 | Breast Cancer | patent blue V d... lymphangiograph... radionuclide im... sentinel lymph ... technetium Tc 9... | 0 Years - 120 Years | UNICANCER | |
| Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics | NCT00656604 | Breast Cancer | proteomic profi... lumpectomy or m... dynamic contras... histopathologic... magnetic resona... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ | NCT00388115 | Breast Cancer | conventional su... neoadjuvant the... radiofrequency ... | 18 Years - | University of California, Davis | |
| Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. | NCT05318274 | Ductal Breast C... Invasive Breast... Early-stage Bre... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... | Hypofractionate... | 18 Years - | Coordinación de Investigación en Salud, Mexico | |
| Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel | NCT01050075 | Breast Cancer Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | acupuncture the... questionnaire a... management of t... | 18 Years - | City of Hope Medical Center | |
| Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer | NCT00002873 | Breast Cancer | brachytherapy | - | Radiation Therapy Oncology Group | |
| S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. | NCT00127205 | Breast Cancer | clodronate diso... ibandronate sod... zoledronic acid | 18 Years - | SWOG Cancer Research Network | |
| Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | NCT00331630 | Breast Cancer | lapatinib ditos... paclitaxel albu... | 18 Years - | Northwestern University | |
| Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | NCT00014222 | Breast Cancer | epoetin alfa filgrastim cyclophosphamid... doxorubicin hyd... epirubicin hydr... fluorouracil paclitaxel | - 60 Years | Canadian Cancer Trials Group | |
| Compliance to a Hormone Therapy Regimen in Breast Cancer | NCT00666822 | Breast Cancer | compliance moni... medical chart r... questionnaire a... | 18 Years - | Case Comprehensive Cancer Center | |
| Survival TRaining for ENhancing Total Health (STRENGTH) | NCT00068458 | Breast Cancer Depression Weight Changes | Calcium-Rich Di... Arm 2: Exercise... Exercise + Frui... | 18 Years - | Duke University | |
| Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer | NCT00516698 | Breast Cancer | polymorphism an... high performanc... laboratory biom... radiomammograph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer | NCT00146562 | Breast Cancer Stage I Breast ... Stage II Breast... | Darbepoetin Alf... Pegfilgrastim Paclitaxel Doxorubicin Cyclophosphamid... | 18 Years - | Dana-Farber Cancer Institute | |
| PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer | NCT00362973 | Breast Cancer | laboratory biom... needle biopsy positron emissi... radionuclide im... fludeoxyglucose... | 18 Years - 120 Years | University of Washington | |
| Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | NCT00301925 | Breast Cancer | pegfilgrastim capecitabine cyclophosphamid... epirubicin hydr... fluorouracil methotrexate adjuvant therap... | 18 Years - 120 Years | Institute of Cancer Research, United Kingdom | |
| St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer | NCT00110136 | Breast Cancer Hot Flashes | St. John's Wort | 18 Years - | Wake Forest University Health Sciences | |
| Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes | NCT00003782 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin | 18 Years - 120 Years | NSABP Foundation Inc | |
| S9630, Medroxyprogesterone in Treating Women With Breast Cancer | NCT00002920 | Breast Cancer Endometrial Can... | medroxyprogeste... tamoxifen citra... adjuvant therap... | 18 Years - | SWOG Cancer Research Network | |
| Strength and Range of Motion in Women Undergoing Surgery for Breast Cancer | NCT00489125 | Breast Cancer | physiologic tes... | - 120 Years | Wake Forest University Health Sciences | |
| Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery | NCT03113825 | Primary Invasiv... Carcinoma Breas... Breast Cancer F... Carcinoma, Duct... Stage II Breast... Stage I Breast ... Stage III Breas... | Investigational... AVB-620 | 18 Years - | Avelas Biosciences, Inc. | |
| Radiation Therapy in Treating Women With Localized Breast Cancer | NCT00107497 | Breast Cancer | Radiation thera... | 50 Years - 120 Years | Institute of Cancer Research, United Kingdom | |
| Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | NCT00003016 | Breast Cancer | tamoxifen citra... adjuvant therap... | - | National Cancer Institute (NCI) | |
| Energy Balance and Breast Cancer Aspects-II | NCT02240836 | DCIS Grade 3 Stage I Breast ... Stage II Breast... LCIS, Lobular C... | Intervention. E... | 18 Years - 75 Years | Oslo University Hospital | |
| Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer | NCT00516698 | Breast Cancer | polymorphism an... high performanc... laboratory biom... radiomammograph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer | NCT00641303 | Anxiety Disorde... Breast Cancer Depression Fatigue Hot Flashes Pain Sleep Disorders | acupuncture the... sham interventi... | 18 Years - | University of Maryland, Baltimore | |
| Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer | NCT00060320 | Breast Cancer Hot Flashes | black cohosh placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer | NCT00004237 | Breast Cancer | cyclophosphamid... doxorubicin hyd... epirubicin hydr... mitoxantrone hy... vinorelbine tar... conventional su... radiation thera... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Acupuncture in Treating Hot Flashes in Women With Breast Cancer | NCT00081965 | Breast Cancer Hot Flashes | acupuncture the... hot flashes att... management of t... | - | Memorial Sloan Kettering Cancer Center | |
| Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer | NCT00290732 | Breast Cancer | Intraductal arm Intravenous arm | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers | NCT01043003 | Breast Cancer Ductal Breast C... Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | educational int... quality-of-life... Questionnaire A... psychosocial su... assessment of t... informational i... | 18 Years - | City of Hope Medical Center | |
| Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer | NCT00005957 | Breast Cancer | Standard Breast... Breast Radiatio... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
| Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer | NCT00182728 | Breast Cancer | surgery therapy radiation thera... | 48 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Radiation Therapy in Treating Women With Early Stage Breast Cancer | NCT00909909 | Breast Cancer | External beam b... whole breast ir... | 18 Years - 120 Years | Rutgers, The State University of New Jersey | |
| Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer | NCT00031811 | Breast Cancer Menopausal Symp... Osteoporosis | raloxifene quality-of-life... | - | OHSU Knight Cancer Institute | |
| Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 | NCT00369850 | Breast Cancer Osteoporosis | laboratory biom... Dual energy X-r... Spine X-ray | 30 Years - | ETOP IBCSG Partners Foundation | |
| Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer | NCT00599989 | Breast Cancer Long-term Effec... Skin Reactions ... | adjuvant therap... conventional su... 3-dimensional c... brachytherapy intracavitary b... proton beam rad... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Improving Communication With Patients With Breast Cancer | NCT00276822 | Breast Cancer | communication i... | 30 Years - 80 Years | Northwestern University | |
| Study of Barriers to Beginning and Finishing Treatment for Patients With Breast Cancer | NCT00937989 | Breast Cancer | educational int... informational i... medical chart r... questionnaire a... study of socioe... quality-of-life... | 50 Years - | City of Hope Medical Center | |
| Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer | NCT03345420 | Ductal Breast C... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... | Hypofractionate... | 18 Years - | University of Utah | |
| Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer | NCT00006030 | Breast Cancer | tamoxifen citra... conventional su... radiation thera... | - 70 Years | National Cancer Institute (NCI) | |
| Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer | NCT00641303 | Anxiety Disorde... Breast Cancer Depression Fatigue Hot Flashes Pain Sleep Disorders | acupuncture the... sham interventi... | 18 Years - | University of Maryland, Baltimore | |
| Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer | NCT00436917 | Breast Cancer Osteoporosis | zoledronic acid Letrozole as ad... | 18 Years - 120 Years | Mayo Clinic | |
| Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms | NCT01194440 | Ductal Carcinom... Estrogen Recept... Progesterone Re... Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | letrozole zoledronic acid | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Radiation Therapy During Surgery in Treating Older Women With Stage I Breast Cancer | NCT00556777 | Breast Cancer | axillary lymph ... conventional su... sentinel lymph ... intraoperative ... | 65 Years - | National Cancer Institute (NCI) | |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | NCT00897793 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer | venipuncture radiation thera... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer | NCT00022087 | Breast Cancer Osteoporosis | calcium salts cholecalciferol zoledronic acid | 40 Years - | Alliance for Clinical Trials in Oncology | |
| Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weight | NCT00343434 | Breast Cancer Obesity | behavioral diet... exercise interv... soy isoflavones soy protein iso... counseling inte... educational int... psychosocial as... quality-of-life... | 21 Years - 120 Years | Wake Forest University Health Sciences | |
| Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | NCT00002580 | Breast Cancer | cyclophosphamid... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... conventional su... laparoscopic su... oophorectomy radiation thera... | - 70 Years | National Cancer Institute (NCI) | |
| Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy | NCT04578106 | HER2-positive B... Stage I Breast ... | Trastuzumab and... | 40 Years - | Fundacio Clinic Barcelona | |
| Survival TRaining for ENhancing Total Health (STRENGTH) | NCT00068458 | Breast Cancer Depression Weight Changes | Calcium-Rich Di... Arm 2: Exercise... Exercise + Frui... | 18 Years - | Duke University | |
| Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer | NCT00084539 | Breast Cancer | Radiation thera... | 18 Years - | Fox Chase Cancer Center | |
| Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ | NCT00438659 | Breast Cancer Dermatologic Co... Radiation Toxic... Skin Reactions ... | mometasone furo... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer | NCT00030758 | Breast Cancer Neutropenia | filgrastim pegfilgrastim | 18 Years - | National Cancer Institute (NCI) | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer | NCT00334542 | Breast Cancer | simvastatin | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | NCT00433407 | Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... | trastuzumab | - | Jonsson Comprehensive Cancer Center | |
| Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer | NCT00295867 | Breast Cancer | Zoledronic Acid | 18 Years - | University of California, San Francisco | |
| Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer | NCT02419807 | Stage I Breast ... Stage II Breast... | Indocyanine Gre... Technetium Tc-9... Lymphoscintigra... Axillary Lymph ... | - | Case Comprehensive Cancer Center | |
| Self-Care for Lymphedema in Patients With Breast Cancer | NCT00670644 | Breast Cancer | questionnaire a... survey administ... quality-of-life... | 18 Years - 120 Years | Vanderbilt University | |
| Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer | NCT00049452 | Breast Cancer Osteoporosis | zoledronic acid | 18 Years - 50 Years | National Cancer Institute (NCI) | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer | NCT00009945 | Breast Cancer | clodronate placebo | 18 Years - | NSABP Foundation Inc | |
| Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer | NCT00334542 | Breast Cancer | simvastatin | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Letrozole After Tamoxifen in Treating Women With Breast Cancer | NCT00003140 | Breast Cancer | letrozole placebo | 0 Years - 120 Years | Canadian Cancer Trials Group | |
| Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer | NCT00086749 | Breast Cancer | 20 Years - 45 Years | Northwestern University | ||
| Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | NCT00301925 | Breast Cancer | pegfilgrastim capecitabine cyclophosphamid... epirubicin hydr... fluorouracil methotrexate adjuvant therap... | 18 Years - 120 Years | Institute of Cancer Research, United Kingdom | |
| Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole | NCT00316836 | Breast Cancer | mammography | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel | NCT01050075 | Breast Cancer Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | acupuncture the... questionnaire a... management of t... | 18 Years - | City of Hope Medical Center | |
| Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors | NCT03284346 | Cancer Survivor No Evidence of ... Obesity Overweight Prostate Carcin... Sedentary Lifes... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Exercise Interv... Exercise Interv... Laboratory Biom... Monitoring Devi... Quality-of-Life... Questionnaire A... | 18 Years - | University of Southern California |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
